1411 / 1983
Larynx preservation: larynx carcinoma
Forastiere et al. NEJM, 2003; JCO, 2013
5-yr-overall survival:
Radiotherapy with concurrent cisplatin
54%
Radiotherapy with neoadjuvant chemotherapy 58%
Conventional radiotherapy alone
55%
Distribution by T-stage: